Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Respiratory syncytial virus outbreak on an adult stem cell transplant unit.

Kelly SG, Metzger K, Bolon MK, Silkaitis C, Mielnicki M, Cullen J, Rooney M, Blanke T, Tahboub A, Noskin GA, Zembower TR.

Am J Infect Control. 2016 Sep 1;44(9):1022-6. doi: 10.1016/j.ajic.2016.03.075. Epub 2016 Jul 15.

PMID:
27430734
2.

Association Between Hospital Characteristics and Performance on the New Hospital-Acquired Condition Reduction Program's Surgical Site Infection Measures.

Minami CA, Dahlke AR, Barnard C, Kinnier CV, Rajaram RR, Noskin GA, Bilimoria KY.

JAMA Surg. 2016 Aug 1;151(8):777-9. doi: 10.1001/jamasurg.2016.0408. No abstract available.

PMID:
27050254
3.

Clinical characteristics and genotypes of rotavirus in adults.

Anderson EJ, Shippee DB, Tate JE, Larkin B, Bregger MD, Katz BZ, Noskin GA, Sederdahl BK, Shane AL, Parashar UD, Yogev R.

J Infect. 2015 Jun;70(6):683-7. doi: 10.1016/j.jinf.2014.11.012. Epub 2014 Dec 4. No abstract available.

PMID:
25481405
4.

Indirect protection of adults from rotavirus by pediatric rotavirus vaccination.

Anderson EJ, Shippee DB, Weinrobe MH, Davila MD, Katz BZ, Reddy S, Cuyugan MG, Lee SY, Simons YM, Yogev R, Noskin GA.

Clin Infect Dis. 2013 Mar;56(6):755-60. doi: 10.1093/cid/cis1010. Epub 2013 Jan 23.

PMID:
23349228
5.

The impact of infection control upon hospital-acquired influenza and respiratory syncytial virus.

Weedon KM, Rupp AH, Heffron AC, Kelly SF, Zheng X, Shulman ST, Gutman P, Wang D, Zhou Y, Noskin GA, Anderson EJ.

Scand J Infect Dis. 2013 Apr;45(4):297-303. doi: 10.3109/00365548.2012.726738. Epub 2012 Oct 31.

PMID:
23113868
6.

Indirect protection and indirect measures of protection from rotavirus in adults.

Anderson EJ, Reddy S, Katz BZ, Noskin GA.

J Infect Dis. 2012 Jun;205(11):1762-4; author reply 1764-5. doi: 10.1093/infdis/jis262. Epub 2012 Mar 28. No abstract available.

PMID:
22457285
7.

Evaluation of postprescription review and feedback as a method of promoting rational antimicrobial use: a multicenter intervention.

Cosgrove SE, Seo SK, Bolon MK, Sepkowitz KA, Climo MW, Diekema DJ, Speck K, Gunaseelan V, Noskin GA, Herwaldt LA, Wong E, Perl TM; CDC Prevention Epicenter Program.

Infect Control Hosp Epidemiol. 2012 Apr;33(4):374-80. doi: 10.1086/664771.

PMID:
22418633
8.

Rotavirus in adults requiring hospitalization.

Anderson EJ, Katz BZ, Polin JA, Reddy S, Weinrobe MH, Noskin GA.

J Infect. 2012 Jan;64(1):89-95. doi: 10.1016/j.jinf.2011.09.003. Epub 2011 Sep 16.

PMID:
21939687
9.

Incidence and impact of false-positive urine pneumococcal antigen testing in hospitalized patients.

Ryscavage PA, Noskin GA, Bobb A, Bardowski L, Zembower TR.

South Med J. 2011 Aug;104(8):593-7. doi: 10.1097/SMJ.0b013e3182273b82.

PMID:
21886070
10.

Native valve endocarditis due to a novel strain of Legionella.

Pearce MM, Theodoropoulos N, Noskin GA, Flaherty JP, Stemper ME, Aspeslet T, Cianciotto NP, Reed KD.

J Clin Microbiol. 2011 Sep;49(9):3340-2. doi: 10.1128/JCM.01066-11. Epub 2011 Jul 27.

11.

Impact of rotavirus vaccination on hospital-acquired rotavirus gastroenteritis in children.

Anderson EJ, Rupp A, Shulman ST, Wang D, Zheng X, Noskin GA.

Pediatrics. 2011 Feb;127(2):e264-70. doi: 10.1542/peds.2010-1830. Epub 2011 Jan 24.

PMID:
21262887
12.

Incidence and types of non-ideal care events in an emergency department.

Hall KK, Schenkel SM, Hirshon JM, Xiao Y, Noskin GA.

Qual Saf Health Care. 2010 Oct;19 Suppl 3:i20-5. doi: 10.1136/qshc.2010.040246. Epub 2010 Aug 19.

PMID:
20724393
13.

Results of the Medications at Transitions and Clinical Handoffs (MATCH) study: an analysis of medication reconciliation errors and risk factors at hospital admission.

Gleason KM, McDaniel MR, Feinglass J, Baker DW, Lindquist L, Liss D, Noskin GA.

J Gen Intern Med. 2010 May;25(5):441-7. doi: 10.1007/s11606-010-1256-6. Epub 2010 Feb 24.

14.

Using patient safety morbidity and mortality conferences to promote transparency and a culture of safety.

Szekendi MK, Barnard C, Creamer J, Noskin GA.

Jt Comm J Qual Patient Saf. 2010 Jan;36(1):3-9.

PMID:
20112658
15.

Antibiotic considerations in the treatment of multidrug-resistant (MDR) pathogens: a case-based review.

Reddy P, Chadaga S, Noskin GA.

J Hosp Med. 2009 Jul;4(6):E8-15. doi: 10.1002/jhm.505. Review.

PMID:
19670375
16.

Infection control practices among interventional radiologists: results of an online survey.

Reddy P, Liebovitz D, Chrisman H, Nemcek AA Jr, Noskin GA.

J Vasc Interv Radiol. 2009 Aug;20(8):1070-1074.e5. doi: 10.1016/j.jvir.2009.04.071.

PMID:
19647184
17.

Using theoretical constructs to identify key issues for targeted message design: African American seniors' perceptions about influenza and influenza vaccination.

Cameron KA, Rintamaki LS, Kamanda-Kosseh M, Noskin GA, Baker DW, Makoul G.

Health Commun. 2009 Jun;24(4):316-26. doi: 10.1080/10410230902889258.

PMID:
19499425
18.

Improved surveillance for surgical site infections after orthopedic implantation procedures: extending applications for automated data.

Bolon MK, Hooper D, Stevenson KB, Greenbaum M, Olsen MA, Herwaldt L, Noskin GA, Fraser VJ, Climo M, Khan Y, Vostok J, Yokoe DS; Centers for Disease Control and Prevention Epicenters Program.

Clin Infect Dis. 2009 May 1;48(9):1223-9. doi: 10.1086/597584.

PMID:
19335165
19.

Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis.

Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA.

J Antimicrob Chemother. 2009 Apr;63(4):816-25. doi: 10.1093/jac/dkp004. Epub 2009 Feb 6.

PMID:
19202150
20.

Use of electronic alerts to enhance hand hygiene compliance and decrease transmission of vancomycin-resistant Enterococcus in a hematology unit.

Venkatesh AK, Lankford MG, Rooney DM, Blachford T, Watts CM, Noskin GA.

Am J Infect Control. 2008 Apr;36(3):199-205. doi: 10.1016/j.ajic.2007.11.005.

PMID:
18371516
21.

Contamination of examination gloves in patient rooms and implications for transmission of antimicrobial-resistant microorganisms .

Diaz MH, Silkaitis C, Malczynski M, Noskin GA, Warren JR, Zembower T.

Infect Control Hosp Epidemiol. 2008 Jan;29(1):63-5. doi: 10.1086/524338.

PMID:
18171189
22.

Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals .

Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M.

Infect Control Hosp Epidemiol. 2008 Jan;29(1):16-24. doi: 10.1086/524327. Erratum in: Infect Control Hosp Epidemiol. 2009 Aug;30(8):815.

PMID:
18171182
23.

Woman with multiple brain abscesses.

Adeyemi OA, Lie O, Bernstein R, Gottardi-Littell N, Muro K, Patil D, Noskin GA.

Clin Infect Dis. 2007 Nov 15;45(10):1351-2, 1397-9. No abstract available.

PMID:
17968834
24.

National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003).

Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M.

Clin Infect Dis. 2007 Nov 1;45(9):1132-40. Epub 2007 Sep 21.

PMID:
17918074
25.

Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes.

Hawkins C, Huang J, Jin N, Noskin GA, Zembower TR, Bolon M.

Arch Intern Med. 2007 Sep 24;167(17):1861-7.

PMID:
17893307
26.

Postoperative vancomycin-resistant Enterococcus faecium endophthalmitis.

Bains HS, Weinberg DV, Feder RS, Noskin GA.

Arch Ophthalmol. 2007 Sep;125(9):1292-3. No abstract available.

PMID:
17846378
27.

Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.

Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, Noskin GA, Zembower T.

Clin Infect Dis. 2007 Oct 1;45(7):846-52. Epub 2007 Aug 20.

PMID:
17806048
28.

Serum piperacillin/tazobactam pharmacokinetics in a morbidly obese individual.

Newman D, Scheetz MH, Adeyemi OA, Montevecchi M, Nicolau DP, Noskin GA, Postelnick MJ.

Ann Pharmacother. 2007 Oct;41(10):1734-9. Epub 2007 Aug 28.

PMID:
17726066
29.

Hospital quality measurement--perplexing for professionals, let alone for patients.

O'Leary KJ, Barnard C, Noskin GA.

J Hosp Med. 2007 May;2(3):119-22. No abstract available.

PMID:
17549774
30.

Postpartum mastitis and community-acquired methicillin-resistant Staphylococcus aureus.

Reddy P, Qi C, Zembower T, Noskin GA, Bolon M.

Emerg Infect Dis. 2007 Feb;13(2):298-301.

31.

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.

Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, Olmsted RN, Bonten M, Lundstrom T, Climo MW, Roghmann MC, Murphy CL, Karchmer TB.

Am J Infect Control. 2007 Mar;35(2):73-85.

32.

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.

Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, Olmsted RN, Bonten M, Lundstrom T, Climo MW, Roghmann MC, Murphy CL, Karchmer TB; Society for Healthcare Epidemiology of America; Association of Professionals in Infection Control and Epidemiology.

Infect Control Hosp Epidemiol. 2007 Mar;28(3):249-60. Epub 2007 Feb 7.

PMID:
17326014
33.

In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.

Scheetz MH, Qi C, Warren JR, Postelnick MJ, Zembower T, Obias A, Noskin GA.

Antimicrob Agents Chemother. 2007 May;51(5):1621-6. Epub 2007 Feb 16.

34.

Discriminating inhalational anthrax from community-acquired pneumonia using chest radiograph findings and a clinical algorithm.

Kyriacou DN, Yarnold PR, Stein AC, Schmitt BP, Soltysik RC, Nelson RR, Frerichs RR, Noskin GA, Belknap SM, Bennett CL.

Chest. 2007 Feb;131(2):489-96.

PMID:
17296652
35.

Improving the assessment of vancomycin-resistant enterococci by routine screening.

Huang SS, Rifas-Shiman SL, Pottinger JM, Herwaldt LA, Zembower TR, Noskin GA, Cosgrove SE, Perl TM, Curtis AB, Tokars JL, Diekema DJ, Jernigan JA, Hinrichsen VL, Yokoe DS, Platt R; Centers for Disease Control and Prevention Epicenters Program.

J Infect Dis. 2007 Feb 1;195(3):339-46. Epub 2006 Dec 27.

PMID:
17205471
36.

Peritoneal fluid penetration of tigecycline.

Scheetz MH, Reddy P, Nicolau DP, Noskin GA, Postelnick MJ, Stosor V, Zembower TR.

Ann Pharmacother. 2006 Nov;40(11):2064-7. Epub 2006 Oct 17.

PMID:
17047138
37.

Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay.

Scarsi KK, Feinglass JM, Scheetz MH, Postelnick MJ, Bolon MK, Noskin GA.

Antimicrob Agents Chemother. 2006 Oct;50(10):3355-60.

38.

The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.

Scheetz MH, Qi C, Noskin GA, Warren JR, Postelnick MJ, Malczynski M, Huang J, Zembower TR.

Diagn Microbiol Infect Dis. 2006 Dec;56(4):407-13. Epub 2006 Aug 23.

PMID:
16930924
39.

A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies.

Bow EJ, Rotstein C, Noskin GA, Laverdiere M, Schwarer AP, Segal BH, Seymour JF, Szer J, Sanche S.

Clin Infect Dis. 2006 Aug 15;43(4):447-59. Epub 2006 Jul 10.

PMID:
16838234
40.

Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens.

Scheetz MH, Hurt KM, Noskin GA, Oliphant CM.

Am J Health Syst Pharm. 2006 Jul 15;63(14):1346-60. Review.

PMID:
16809756
41.

A multicenter intervention to prevent catheter-associated bloodstream infections.

Warren DK, Cosgrove SE, Diekema DJ, Zuccotti G, Climo MW, Bolon MK, Tokars JI, Noskin GA, Wong ES, Sepkowitz KA, Herwaldt LA, Perl TM, Solomon SL, Fraser VJ; Prevention Epicenter Program.

Infect Control Hosp Epidemiol. 2006 Jul;27(7):662-9. Epub 2006 Jun 9.

PMID:
16807839
42.

Assessment of materials commonly utilized in health care: implications for bacterial survival and transmission.

Lankford MG, Collins S, Youngberg L, Rooney DM, Warren JR, Noskin GA.

Am J Infect Control. 2006 Jun;34(5):258-63.

PMID:
16765202
43.

Active surveillance using electronic triggers to detect adverse events in hospitalized patients.

Szekendi MK, Sullivan C, Bobb A, Feinglass J, Rooney D, Barnard C, Noskin GA.

Qual Saf Health Care. 2006 Jun;15(3):184-90.

44.

Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.

Scheetz MH, Wunderink RG, Postelnick MJ, Noskin GA.

Pharmacotherapy. 2006 Apr;26(4):539-50. Review.

PMID:
16553514
45.

Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement.

Gerber SI, Jones RC, Scott MV, Price JS, Dworkin MS, Filippell MB, Rearick T, Pur SL, McAuley JB, Lavin MA, Welbel SF, Garcia-Houchins S, Bova JL, Weber SG, Arnow PM, Englund JA, Gavin PJ, Fisher AG, Thomson RB, Vescio T, Chou T, Johnson DC, Fry MB, Molloy AH, Bardowski L, Noskin GA.

Infect Control Hosp Epidemiol. 2006 Feb;27(2):139-45. Epub 2006 Feb 8.

PMID:
16465630
46.

Risk factors and outcomes associated with non-Enterococcus faecalis, non-Enterococcus faecium enterococcal bacteremia.

de Perio MA, Yarnold PR, Warren J, Noskin GA.

Infect Control Hosp Epidemiol. 2006 Jan;27(1):28-33. Epub 2006 Jan 6.

PMID:
16418983
47.

Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program.

Warren DK, Yokoe DS, Climo MW, Herwaldt LA, Noskin GA, Zuccotti G, Tokars JI, Perl TM, Fraser VJ.

Infect Control Hosp Epidemiol. 2006 Jan;27(1):8-13. Epub 2006 Jan 6.

PMID:
16418980
48.

Efficacy and safety of scheduled dosing of opioid analgesics: a quality improvement study.

Paice JA, Noskin GA, Vanagunas A, Shott S.

J Pain. 2005 Oct;6(10):639-43.

PMID:
16202955
49.

Effect of on-call infectious-diseases pharmacists on antibiotic expenditures.

Scheetz MH, Postelnick MJ, Scarsi KK, Gerzenshtein L, Bolon MK, Fotis M, Noskin GA.

Am J Health Syst Pharm. 2005 Oct 1;62(19):1967-8. No abstract available.

PMID:
16174825
50.

The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database.

Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Smulders M, Lapetina E, Gemmen E.

Arch Intern Med. 2005 Aug 8-22;165(15):1756-61.

PMID:
16087824

Supplemental Content

Loading ...
Support Center